Download PDF
Planta Med 2012; 78(1): 12-17
DOI: 10.1055/s-0031-1280219
Biological and Pharmacological Activity
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

ZYM-201 Sodium Succinate Ameliorates Streptozotocin-Induced Hyperlipidemic Conditions

Jongwon Choi1 [*] , Mi-Yeon Kim2 [*] , Bae Cheon Cha3 , Eun Sook Yoo4 , Keejung Yoon5 , Jaehwi Lee6 , Ho Sik Rho7 , Sun Young Kim8 , Jae Youl Cho5
  • 1College of Pharmacy, Kyungsung University, Busan, Korea
  • 2School of Systems Biological Science, Soongsil University, Seoul, Korea
  • 3College of Health Sciences, Sangji University, Wonju, Korea
  • 4College of Medicine, Cheju National University, Jeju, Korea
  • 5Department of Genetic Engineering, Sungkyunkwan University, Suwon, Korea
  • 6College of Pharmacy, Chung-Ang University, Seoul, Korea
  • 7Medical Beauty Research Institute, AmorePacific R & D Center, Yongin, Korea
  • 8Hongcheon Institute of Medicinal Herb, Hongcheon, Korea
Further Information

Publication History

received February 8, 2011 revised August 4, 2011

accepted August 16, 2011

Publication Date:
16 September 2011 (online)

    Permissions and Reprints

Abstract

ZYM-201 is a methyl ester of a novel triterpenoid glycoside. It is isolated from Sanguisorba officinalis, a widely used medicinal plant in Korea, China, and Japan, that is prescribed for various diseases such as diarrhea, chronic intestinal infections, duodenal ulcers, and bleeding. In this study, the antihyperlipidemic effect of the salt form (sodium succinate) of ZYM-201 was examined using streptozotocin (STZ)-treated hyperglycemic rats. Oral administration of ZYM-201 sodium succinate (3 to 10 mg/kg) resulted in recovery of the increased serum levels of triglyceride (TG) and total cholesterol (TC) back to normal levels. Elevated levels of serum lipoproteins, such as high-density lipoprotein (HDL), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL), were also significantly restored by this compound without altering 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase activity. Finally, ZYM-201 sodium succinate displayed antioxidative properties, including suppression of lipid peroxide and hydroxyl radical generation and upregulation of superoxide dismutase (SOD) activity. Therefore, our data strongly suggest that ZYM-201 sodium succinate can be used as a remedy for the treatment of diabetes-derived hyperlipidemic disorders such as atherosclerosis and vascular diseases.

Key words

ZYM-201 sodium succinate - Sanguisorba officinalis L. - Rosaceae - triterpenoid glycoside - diabetes - antihyperlipidemic activity

References

  • 1 Hvidtfeldt U A, Frederiksen M E, Thygesen L C, Kamper-Jorgensen M, Becker U, Gronbaek M. Incidence of cardiovascular and cerebrovascular disease in Danish men and women with a prolonged heavy alcohol intake.  Alcohol Clin Exp Res. 2008;  32 1920-1924
    PubMedGoogle Scholar
  • 2 Connor W E, Connor S L. Diet, atherosclerosis, and fish oil.  Adv Intern Med. 1990;  35 139-171
    PubMedGoogle Scholar
  • 3 Taniguchi M, Yasutake A, Takedomi K, Inoue K. Effects of N-nitrosodimethylamine (NDMA) on the oxidative status of rat liver.  Arch Toxicol. 1999;  73 141-146
    CrossrefPubMedGoogle Scholar
  • 4 Gomez J, Caro P, Naudi A, Portero-Otin M, Pamplona R, Barja G. Effect of 8.5 % and 25 % caloric restriction on mitochondrial free radical production and oxidative stress in rat liver.  Biogerontology. 2007;  8 555-566
    CrossrefPubMedGoogle Scholar
  • 5 Matsuo M, Ito F, Konto A, Aketa M, Tomoi M, Shimomura K. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.  Biochim Biophys Acta. 1995;  1259 254-260
    CrossrefPubMedGoogle Scholar
  • 6 Leitersdorf E. Selective cholesterol absorption inhibition: a novel strategy in lipid-lowering management.  Int J Clin Pract. 2002;  56 116-119
    PubMedGoogle Scholar
  • 7 Cho J Y, Yoo E S, Cha B C, Park H J, Rhee M H, Han Y N. The inhibitory effect of triterpenoid glycosides originating from Sanguisorba officinalis on tissue factor activity and the production of TNF-alpha.  Planta Med. 2006;  72 1279-1284
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Asao Y, Morikawa T, Xie Y, Okamoto M, Hamao M, Matsuda H, Muraoka O, Yuan D, Yoshikawa M. Structures of acetylated oleanane-type triterpene saponins, rarasaponins IV, V, and VI, and anti-hyperlipidemic constituents from the pericarps of Sapindus rarak.  Chem Pharm Bull (Tokyo). 2009;  57 198-203
    CrossrefPubMedGoogle Scholar
  • 9 Lee K T, Sohn I C, Kim D H, Choi J W, Kwon S H, Park H J. Hypoglycemic and hypolipidemic effects of tectorigenin and kaikasaponin III in the streptozotocin-lnduced diabetic rat and their antioxidant activity in vitro.  Arch Pharm Res. 2000;  23 461-466
    CrossrefPubMedGoogle Scholar
  • 10 Maiti R, Das U K, Ghosh D. Attenuation of hyperglycemia and hyperlipidemia in streptozotocin-induced diabetic rats by aqueous extract of seed of Tamarindus indica.  Biol Pharm Bull. 2005;  28 1172-1176
    CrossrefPubMedGoogle Scholar
  • 11 Ravi K, Rajasekaran S, Subramanian S. Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocin-induced diabetes in rats.  Food Chem Toxicol. 2005;  43 1433-1439
    PubMedGoogle Scholar
  • 12 Kim H J, Chae I G, Lee S G, Jeong H J, Lee E J, Lee I S. Effects of fermented red ginseng extracts on hyperglycemia in streptozotocin-induced diabetic rats.  J Ginseng Res. 2010;  34 369-375
    CrossrefPubMedGoogle Scholar
  • 13 Park Y S, Choi J, Kim K Y, Lim J S, Yoon S, Yang Y. A novel PPAR gamma agonist, SP1818, shows different coactivator profile with rosiglitazone.  Biomol Ther. 2010;  18 77-82
    CrossrefPubMedGoogle Scholar
  • 14 Nikkari T, Schreibman P H, Ahrens jr. E H. In vivo studies of sterol and squalene secretion by human skin.  J Lipid Res. 1974;  15 563-573
    PubMedGoogle Scholar
  • 15 Min S W, Jung S H, Cho K H, Kim D H. Antihyperlipidemic effects of red ginseng, Crataegii fructus and their main constituents ginsenoside Rg3 and ursolic acid in mice.  Biomol Ther. 2008;  16 364-369
    CrossrefPubMedGoogle Scholar
  • 16 Takahashi T, Hirano T, Okada K, Adachi M. Apolipoprotein CIII deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic mice.  Metabolism. 2003;  52 1354-1359
    CrossrefPubMedGoogle Scholar
  • 17 Sagone jr. A L, Decker M A, Wells R M, Democko C. A new method for the detection of hydroxyl radical production by phagocytic cells.  Biochim Biophys Acta. 1980;  628 90-97
    CrossrefPubMedGoogle Scholar
  • 18 Giada F, Baldo-Enzi G, Balocchi M R, Zuliani G, Baroni L, Fellin R. Heparin-released plasma lipase activities, lipoprotein and apoprotein levels in young adult cyclists and sedentary men.  Int J Sports Med. 1988;  9 270-274
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Fraga C G, Leibovitz B E, Tappel A L. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes.  Free Radic Biol Med. 1988;  4 155-161
    CrossrefPubMedGoogle Scholar
  • 20 Wahlund G, Marklund S L, Sjoquist P O. Extracellular-superoxide dismutase type C (EC-SOD C) reduces myocardial damage in rats subjected to coronary occlusion and 24 hours of reperfusion.  Free Radic Res Commun. 1992;  17 41-47
    CrossrefPubMedGoogle Scholar
  • 21 Ametaj B N, Bobe G, Lu Y, Young J W, Beitz D C. Effect of sample preparation, length of time, and sample size on quantification of total lipids from bovine liver.  J Agric Food Chem. 2003;  51 2105-2110
    CrossrefPubMedGoogle Scholar
  • 22 Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.  Anal Biochem. 1976;  72 248-254
    CrossrefPubMedGoogle Scholar
  • 23 Kwak Y S, Kyung J S, Kim J S, Cho J Y, Rhee M H. Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng.  Biol Pharm Bull. 2010;  33 468-472
    CrossrefPubMedGoogle Scholar
  • 24 Lee H S, Woo S J, Ku S K. Hypolipidemic and hepatoprotective effects of Picrorrhiza rhizoma in high fat diet supplied mice. A prevention study.  Biomol Ther. 2008;  16 46-53
    CrossrefPubMedGoogle Scholar
  • 25 Yua H D, Kim S J, Quan H Y, Huang B, Chung S H. Ginseng leaf extract prevents high fat diet-induced hyperglycemia and hyperlipidemia through AMPK activation.  J Ginseng Res. 2010;  34 369-375
    CrossrefPubMedGoogle Scholar
  • 26 Nakashima A, Nakashima R, Ito T, Masaki T, Yorioka N. HMG-CoA reductase inhibitors prevent bone loss in patients with type 2 diabetes mellitus.  Diabet Med. 2004;  21 1020-1024
    CrossrefPubMedGoogle Scholar
  • 27 Wang C S, Weingand K W, Anthony M S. Effect of atherogenic diet on lipoprotein lipase activity in cynomolgus monkeys.  Atherosclerosis. 1987;  67 173-180
    CrossrefPubMedGoogle Scholar
  • 28 Afrose S, Hossain M S, Maki T, Tsujii H. Effects of karaya saponin and Rhodobacter capsulatus on yolk cholesterol in laying hens.  Br Poult Sci. 2010;  51 409-418
    CrossrefPubMedGoogle Scholar
  • 29 Hu X Q, Wang Y M, Wang J F, Xue Y, Li Z J, Nagao K, Yanagita T, Xue C H. Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling.  Lipids Health Dis. 2010;  9 25
    CrossrefPubMedGoogle Scholar
  • 30 Popovich D G, Li L, Zhang W. Bitter melon (Momordica charantia) triterpenoid extract reduces preadipocyte viability, lipid accumulation and adiponectin expression in 3T3-L1 cells.  Food Chem Toxicol. 2010;  48 1619-1626
    CrossrefPubMedGoogle Scholar
  • 31 Collino M, Patel N S, Thiemermann C. PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury.  Ther Adv Cardiovasc Dis. 2008;  2 179-197
    CrossrefPubMedGoogle Scholar
  • 32 Noh J R, Kim Y H, Gang G T, Yang K J, Kim S K, Ryu S Y, Kim Y S, Lee C H, Lee H S. Preventative effects of Platycodon grandiflorum treatment on hepatic steatosis in high fat diet-fed C57BL/6 mice.  Biol Pharm Bull. 2010;  33 450-454
    CrossrefPubMedGoogle Scholar
  • 33 Cohn J S, Kamili A, Wat E, Chung R W, Tandy S. Reduction in intestinal cholesterol absorption by various food components: mechanisms and implications.  Atheroscler Suppl. 2010;  11 45-48
    PubMedGoogle Scholar
  • 34 Stevens M J. Oxidative-nitrosative stress as a contributing factor to cardiovascular disease in subjects with diabetes.  Curr Vasc Pharmacol. 2005;  3 253-266
    CrossrefPubMedGoogle Scholar
  • 35 Zaware P, Shah S R, Pingali H, Makadia P, Thube B, Pola S, Patel D, Priyadarshini P, Suthar D, Shah M, Jamili J, Sairam K V, Giri S, Patel L, Patel H, Sudani H, Patel H, Jain M, Patel P, Bahekar R. Modulation of PPAR subtype selectivity. Part 2: Transforming PPARalpha/gamma dual agonist into alpha selective PPAR agonist through bioisosteric modification.  Bioorg Med Chem Lett. 2011;  21 628-632
    CrossrefPubMedGoogle Scholar

1 These authors contributed equally to this work.

Jae Youl Cho, PhD

Department of Genetic Engineering
Sungkyunkwan University

300 Chuncheon-dong

Suwon 440-746

Korea

Phone: +82 31 2 90 78 68

Fax: +82 31 2 90 78 70

Email: jaecho@skku.edu

Jaehwi Lee, PhD

College of Pharmacy
Chung-Ang University

221 Heukseok-dong

Seoul 156-756

Korea

Phone: +82 2 8 20 56 06

Fax: +82 2 8 16 73 38

Email: jaehwi@cau.ac.kr

      >